Anbio Biotechnology (NASDAQ:NNNN) Shares Gap Down – Time to Sell?
by Danessa Lincoln · The Markets DailyAnbio Biotechnology (NASDAQ:NNNN – Get Free Report)’s stock price gapped down before the market opened on Friday . The stock had previously closed at $11.49, but opened at $10.94. Anbio Biotechnology shares last traded at $11.0250, with a volume of 1,799 shares traded.
Wall Street Analyst Weigh In
Separately, Weiss Ratings upgraded shares of Anbio Biotechnology from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Thursday, May 14th. One analyst has rated the stock with a Hold rating, Based on data from MarketBeat.com, Anbio Biotechnology presently has a consensus rating of “Hold”.
Read Our Latest Stock Report on Anbio Biotechnology
Anbio Biotechnology Stock Performance
The stock’s 50-day simple moving average is $22.17.
Anbio Biotechnology (NASDAQ:NNNN – Get Free Report) last issued its quarterly earnings results on Tuesday, April 7th. The company reported $0.03 earnings per share for the quarter.
Anbio Biotechnology Company Profile
Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs.